Terra Nova Asset Management LLC Has $485,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Terra Nova Asset Management LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 80.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,615 shares of the company’s stock after selling 6,497 shares during the period. Terra Nova Asset Management LLC’s holdings in HCA Healthcare were worth $485,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in HCA. Massmutual Trust Co. FSB ADV raised its holdings in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock valued at $171,000 after purchasing an additional 29 shares in the last quarter. Waldron Private Wealth LLC increased its holdings in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after acquiring an additional 29 shares during the last quarter. Brookstone Capital Management boosted its position in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after purchasing an additional 30 shares during the period. UMB Bank n.a. raised its position in shares of HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after purchasing an additional 30 shares during the period. Finally, Integrated Advisors Network LLC grew its stake in HCA Healthcare by 0.6% in the 3rd quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock valued at $2,086,000 after buying an additional 31 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 0.4 %

NYSE HCA opened at $310.60 on Monday. The stock has a fifty day moving average of $316.69 and a 200-day moving average of $353.01. The stock has a market capitalization of $78.67 billion, a P/E ratio of 13.95, a price-to-earnings-growth ratio of 1.03 and a beta of 1.64. HCA Healthcare, Inc. has a 52 week low of $278.50 and a 52 week high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Investors of record on Friday, December 13th were paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Truist Financial cut their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Finally, Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their target price for the stock from $400.00 to $320.00 in a research report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $385.27.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.